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Abstract: Biological systems are increasingly being studied in a holistic manner, using omics approaches, to provide 
quantitative and qualitative descriptions of the diverse collection of cellular components. Among the omics approaches, 
metabolomics, which deals with the quantitative global profiling of small molecules or metabolites, is being used 
extensively to explore the dynamic response of living systems, such as organelles, cells, tissues, organs and whole 
organisms, under diverse physiological and pathological conditions. This technology is now used routinely in a number of 
applications, including basic and clinical research, agriculture, microbiology, food science, nutrition, pharmaceutical 
research, environmental science and the development of biofuels. Of the multiple analytical platforms available to 
perform such analyses, nuclear magnetic resonance and mass spectrometry have come to dominate, owing to the high 
resolution and large datasets that can be generated with these techniques. The large multidimensional datasets that result 
from such studies must be processed and analyzed to render this data meaningful. Thus, bioinformatics tools are essential 
for the efficient processing of huge datasets, the characterization of the detected signals, and to align multiple datasets and 
their features. This paper provides a state-of-the-art overview of the data processing tools available, and reviews a 
collection of recent reports on the topic. Data conversion, pre-processing, alignment, normalization and statistical analysis 
are introduced, with their advantages and disadvantages, and comparisons are made to guide the reader.  
Keywords: Bioinformatics, mass spectrometry, metabolome, metabolomics, software development, statistical analysis, systems 
biology.  
1. INTRODUCTION 
  Metabolomics or metabolome analysis aims to conduct 
the simultaneous determination and quantitative analysis of 
intracellular metabolites. Since metabolomics is concerned 
with small molecules that are the substrates and products, of 
cellular activity, it allows to explore in a direct and 
immediate way the biological system/environment interface. 
This can be appreciated by the great sensitivity of metabolite 
levels to subtle pharmacological and toxicological 
intervention [1-6]. As a consequence, metabolomics is 
playing an increasingly important role in systems biology, a 
field that aims to integrate information collected at multiple 
biological levels. It is now used widely in many applications 
including microbiology, diagnostic biomarker discovery, 
toxicological testing, food and beverage analysis, plant and 
animal phenotyping, and drug discovery and development 
[7-12]. 
  Nuclear magnetic resonance (NMR) is one of the most 
commonly used analytical techniques in metabolomics   
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studies [13]. To date, a number of large-scale, studies using 
NMR have been reported, including blood urine and serum 
metabolome profiling [14-15]. This technique has been 
popular in metabolomic studies because of its quantitative 
nature and high reproducibility. In addition, NMR spectra 
provide a wealth of biochemical information not available by 
other means [16-20]. It also has definitive advantage that it 
can be used in non-destructive ways to enable metabolomic 
profiling in vivo [21-22] and even allow metabolite imaging 
in biological samples [23-24]. However, the relatively low 
sensitivity of NMR, and the spectral overlap that often 
occurs, limits the number and variety of metabolites that can 
be simultaneously observed. Hyphenated mass spectrometry 
(MS) methods, such as GC-MS [25], LC-MS [26] and CE-
MS [27], currently provide higher sensitivity, and are the 
leading analytical platform for metabolite profiling [28-31]. 
Because of the diverse physical and chemical properties (for 
example, molecular weight, polarity and solubility) of the 
metabolites contained in typical samples, no single analytical 
methodology can profile datasets comprehensively. Thus, 
metabolomics, in the strictest sense, is very challenging, 
and the term is used broadly to cover approaches concerned 
with investigating subsets of the metabolome [32]. GC-MS, 
LC-MS and CE-MS are generally capable of profiling 
volatile, singly or multiply charged metabolites. Hyphenated 
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MS methods involve the use of a physico-chemical 
separation method in tandem with a mass spectrometer, 
which is used for detection. These systems thus produce data 
that is multidimensional with a time and mass/charge ratio 
component. The multidimensionality of the data increases 
the data processing challenges posed by metabolomics.  
  Because metabolomics deals with large datasets like 
other omics, sophisticated computational tools are vital for 
efficient and high-throughput analysis, to eliminate 
systematic bias and to explore biologically significant 
findings. In this paper, we review bioinformatics topics in 
the field of metabolomics, with an emphasis on hyphenated-
MS methods, especially LC-MS and CE-MS. As some of 
these topics have been well reviewed previously [33-51], we 
emphasize the most recent innovations and developments in 
the field. In the first part, we review the main data 
processing steps, including data formats/conversion, feature 
extraction/detection, comparison of multiple datasets 
including migration time and mass spectral alignment, signal 
normalization and identification of metabolites, and quality 
control (QC). The second part focuses on downstream data 
analysis of processed datasets, using univariate or 
multivariate statistical analyses, classification and clustering. 
We also discuss the standardization of data format, compare 
some of the leading software tools that implement different 
algorithms for data processing and discuss data interpretation 
for different research applications. 
2. DATA PROCESSING FOR METABOLOMICS 
ANALYSIS 
  Typical data processing flow for MS data has been 
previously reviewed by Katajamaa and Orei [34], and is 
now implemented in a variety of software packages [52-57]. 
The analytical usually flow starts from data conversion, 
detecting signal peaks, normalization and comparison of 
multiple datasets to generate a data matrix that includes the 
detected peaks of all given samples (alignment). The 
differentiation of signals from noise by interpretation of the 
mass spectrum and the identification of detected features 
using, for example, alignments with standard compound 
data, are also important. Finally, processed data are analyzed 
using statistical methods and data mining. A recent addition 
to this straightforward analytical process is the quality 
control (QC) of data processing. This process does not 
simply involve the use of QC methods after data processing 
[58], but rather is used as part of an iterative feedback loop 
between data processing and QC [59] (Fig. 1). 
  The following section introduces recent literature related 
to 1) data conversion, 2) feature detection, 3) alignment, 4) 
scaling/normalization, 5) identification, and 6) QC. See also 
the following references: [58, 60-61]. 
2.1. Data Conversion 
  Data processing starts with file format conversion from 
the MS-vendor dependent binary format to more common 
formats, to allow subsequent processing to be carried out on 
independent operation systems and software. A common and 
open framework and data description is important if data are 
to be shared among laboratories [62-64]. NetCDF and 
mzXML are the most commonly used file formats to store 
hyphenated-MS data [65]. Owing to recent rapid 
improvements in the throughput and resolution of MS, 
individual data files have become large, which compounds 
problems associated with the large numbers of datasets 
handled in metabolomics projects. Although these common 
file formats simplify data sharing between laboratories, the 
problem of handling a large number of large datasets 
remains. While removing small intensity peaks and data 
compression using irreversible filtering, as can be 
implemented in mzMine [56] and mzMine2 [52], is the 
simplest way to diminish data size, they risk distorting 
subsequent data analysis. Although Mass++ allows the direct 
import of various binary files provided by MS venders into 
standard software [66], it merely accesses the binary data 
through a vendor-provided application programmable 
interface (API). This dramatically reduces throughput and 
does not solve the problem of MS-vendor software 
dependency. Although it cannot be shown directly without 
access to the source code, most vendor-provided 
hyphenated-MS instrument binary formats (for example, 
wiff files and .D formats provided by Applied Biosystems 
and Agilent Technologies Inc.) can be estimated to contain a 
series of mass spectra data, since mass spectra are usually 
collected in this way. This data structure results in much 
longer data access times to output a chromatograph or an 
electropherogram if the data points included in the mass 
spectra are not unique over the chromatograph or 
electropherogram. To solve these size and structure 
problems, we developed a compact binary file format that 
facilitates rapid access to chromatographs or 
electropherograms and mass spectra [67]. Although there is 
currently a trade-off between facilitating quick data access 
and the availability of a generic file format, the development 
and standardization of file formats that fulfill the 
requirement for rapid access should be a priority. 
 
Fig. (1). Typical processing flow of MS data in the field of 
metabolomics. Raw data are sequentially processed in multiple 
phases, including file conversion, feature detection, alignment and 
normalization. Standard data and public databases that include 
metabolite information, such as mass spectrometric data, are used 
for subsequent feature identification. These processes are then 
assessed using quality control criteria and the previous phase is 
repeated if necessary. Once calibrated, the data matrix (aligned 
detected features across multiple datasets) can be transferred for 
subsequent data analysis phases. 
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2.2. Feature Detection 
  In the typical analytical flow, three-dimensional data 
incorporating retention or migration times, m/z and intensity 
data are first converted to piles of two-dimensional 
chromatography/electropherograms, by integrating data 
points within a specific range along the m/z axis (ion 
extraction or data binning). Second, background reduction 
(or baseline removal) and smoothing of the data are 
conducted to reduce false positive detection. Third, local 
maxima are found as peak top candidates, or a mathematical 
model is fitted to find peak-like shapes within the 
chromatographs or electropherograms. These are used to 
identify peaks over a user-specified threshold, which may be 
in the form of a peak height, peak area or signal-to-noise 
(S/N) ratio [52-54, 67-68]. Although wavelet transformation 
and Gaussian-curve fitting (or matched filter) is a commonly 
used means to distinguish signal from noise [53, 68], fully 
automatic processing remains difficult owing to the complex 
peak shapes often observed in LC-MS and, in particular, CE-
MS. Interactive tuning of the algorithms is therefore often 
required [52, 67]. Other options are to identify peaks at 
matched locations (m/z and time), even under the initially-
defined threshold after the alignment process [69]. Such 
feedback procedures and QC will be discussed further in 
section 2.7. 
2.3. Alignment of Multiple Data Sets 
  The alignment of multiple datasets, i.e. the elimination of 
retention or migration times shifts between datasets, is a 
central topic of data processing in the metabolomics field, 
and is associated with specific technical difficulties. 
Therefore, many alignment techniques have been developed 
[70]. The retention time variance of GC-MS and LC-MS 
datasets is non-linear [71], and thus multiple sophisticated 
time correction methods have been developed. The 
alignment of CE-MS data is especially difficult because of 
the low reproducibility of migration times [54], and robust 
and versatile alignment procedures are therefore required. 
Here, we review the three major alignment algorithms used 
for the temporal dimension. In addition, the normalization of 
mass/charge ratio (m/z) calculated by MS is also introduced. 
Time Correlation Optimized Warping 
  Time correlation optimized warping (COW) divides 
chromatograms into small segments and shifts individual 
segments to maximize the correlation coefficient between a 
reference and test chromatograph. The algorithm itself has 
inherent problems; a larger number of segments leads to 
greater accuracy, but raises the risk of dividing the targeted 
metabolite peaks. To optimize the degree of segmentation, 
the use of heuristic and global optimization processes, such 
as genetic algorithms, has been proposed [72]. To date, 
benchmark tests with only small numbers of peaks have been 
performed [72], and the method should be evaluated using 
data with a large number of peaks, observed by high 
resolution MS. 
Parametric Time Warping  
  The parametric time warping method aligns a given 
chromatogram with a reference chromatogram using second 
degree polynomial functions, called warping functions [73]. 
Coefficients in warping functions are optimized to minimize 
the time difference between selected matched peaks in 
reference and aligned chromatograms. Thus, the method 
relies on the presence of a number of known matched peaks 
among the samples to be aligned. Although the addition of 
internal standards (IS) is the most simple way to achieve 
this, it has several disadvantages: (i) suitable IS compounds 
must be carefully selected, for example the IS compounds 
must not normally be present in the samples; (ii) additional 
sample preparation is required; and most significantly (iii) 
the added IS may cause ion suppression effects and degrade 
the quantitative reliability of the observed profiles. Despite 
these problems, rapid computation time is an important 
advantage of this method. Lower flexibility and accuracy has 
been reported for this method in comparison with COW and 
dynamic time warping (DTW) [70].  
Dynamic Time Warping 
  DTW finds the matched peaks among multiple datasets 
automatically to produce warping functions. Dynamic 
programming (DP) has historically been used in homology 
searching of genes or genomes, and has been used for 
matching peaks [74]. The parameters that characterize DP 
results, such as gap penalty, make this method parametric. 
Thus, empirical reiterative multi-step optimization of these 
parameters has been used in CE-MS data processing 
software [54] and interactive graphical user interfacing [67]. 
In contrast, recent modifications to DTW using multiple 
chromatograms with different m/z, instead of one-
dimensional information available from total ion 
chromatography, reduced the impact of the parametric 
problems embedded in the original DTW algorithm [75]. 
Calibration of Mass Values (m/z Alignment) 
  Exact masses (mass-to-charge ratio (m/z) values), 
produced by detectors in time-of-flight (TOF)-MS 
instruments are usually calculated based on online 
calibration with one or more reference substances that are 
co-injected with the sample. This is known as the mass lock 
system [76]. The m/z values detected for individual peaks 
fluctuate depending on several factors, including 
temperature, the abundance of ions simultaneously entering 
the MS, and the processing ability, type and specifications of 
the MS detector [77]. Thus, the data acquired should be 
further calibrated. Typically a calibration curve generated 
using the peaks of known m/z is applied to correct m/z values 
of other peaks of interest (offline or software calibration) 
[78-80]. The m/z values are intricately calibrated for the 
whole chromatograph or electropherogram time axis, since 
the factors influencing m/z shifts can change even during the 
course of a single run [81]. In addition, m/z value correction 
can be carried out using peak intensities relative to the 
intensities of internal standards [82], using the location of 
background noise observed throughout the measurement 
[83], and using statistical approaches with multiple datasets 
[69]. Ideally, these methods should be integrated to optimize 
m/z normalization. 
2.4. Scaling and Normalization 
  The elimination of unwanted systematic bias, while 
maintaining genuine biological differences in the observed 
datasets, is essential for subsequent analyses to identify 
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variation in sample concentration, especially when handling 
biofluids such as urine, blood and saliva samples, must be 
removed. Deviation in signal intensities due to measurement 
errors, for example poor MS sensitivity, must also be 
removed. To address the former problem, metabolomic 
analyses typically use endogenous metabolites, for example 
creatinine, to normalize overall urine metabolite 
concentrations [84]. However, this method is not always 
sufficient to eliminate systematic bias, and a recent mouse 
metabolomic study revealed a correlation between overall 
urinary metabolites and several physical parameters, such as 
age and weight [85]. The latter bias is generally removed 
using two approaches. Despite the increased technical 
complexity of sample preparation, the use of internal 
standard compounds added to the sample before or after 
extraction is the most common approach. The use of multiple 
internal standards to normalize closely eluting peaks with 
similar m/z values has also been reported [86]. Otherwise, 
normalization methods based on several statistical models 
(unit norm [87] median [88] and quantile [58]), scaling 
methods (auto scaling, range scaling, Pareto scaling, vast 
scaling and level scaling) [61], and data transformation (log 
and power) have been widely used. These methods are, 
however, inferior to the internal standard-based methods 
[58]. 
2.5. Identification of Metabolites 
  Global metabolic profiles or fingerprints that do not 
necessarily assign observed features to particular metabolites 
can be very powerful means of classifying and directly 
comparing samples. They highlight metabolomics as 
providing a global molecular signature allowing us to 
discriminate groups of samples in contrast to more 
conventional comparisons based on single metabolite. 
However, metabolite identification from spectral data 
remains indispensable for providing mechanistic insight into 
specific cellular or disease processes and in quality 
control/assurance industry, for example. The accurate 
identification of a compound usually requires the ability to 
match candidate spectra with standard compounds run under 
the same conditions. Matching to either externally or 
internally applied standards has been commonly used, the 
latter making use of isotopically labeled standards or 
samples. However, the lack of readily available standard 
compounds remains a major obstacle to confirming the 
identity of observed compounds. The purification of 
compounds from complex samples allows access to 
standards; however, this can be an expensive and time-
consuming process. Several tools that estimate compound 
composition using isotope distribution or fragmentation 
patterns in the mass spectrum have been developed [89-92]. 
Databases that include a large number candidate compounds 
are also indispensable (see review [43]). A theoretical study 
estimated that the mass spectral information available from 
mass spectrometers with accuracy approaching 1 ppm, such 
as TOFMS, is not sufficient to identify peaks without a 
matched standard compound, as multiple candidate 
compounds are often retrieved from the large public 
databases [93]. The Human Metabolome Project has already 
identified more than 4,000 putative endogenous metabolites 
from human serum using GC-MS, LC-MS and NMR profiles 
with computer-aided literature mining [12]. Many studies 
thus use tandem MS, which generates more informative 
spectra including many fragment peaks, for compound 
identification [94-95]. Efforts have also been made to use 
retention time information to reduce the number of possible 
candidates. These efforts are based on reverse engineering 
techniques [96-99] or theoretical simulation [100], which 
predict the retention/migration times from the metabolite 
structure. The quantification of observed peaks in the 
absence of matched standard compounds is also difficult, but 
computational prediction techniques have been developed 
[101]. The combined use of such computational methods can 
greatly reduce the number of candidates and aid metabolite 
identification. 
2.6. Quality Control of Data Processing 
  A number of algorithms have been developed for data 
processing, especially for peak detection and alignment, and 
various parameters can be used to characterize the quality of 
data processing [59]. The selection of the best algorithm, and 
the best parameters, to analyze the datasets obtained is not an 
easy task. Thus, QC evaluation based on various benchmark 
tests is important to understand the features of each 
algorithm and their parameters [102]. 
  A comparison of peak detection algorithms of LC-MS 
data using centWave [68], matched filter implemented in 
XCMS [53] and MZmine [56] showed that there was only a 
partial overlap in the results obtained with these methods, 
and a number of peaks were only detected by one software 
(not overlapped) [68]. Even with the same algorithm, the use 
of different parameters strongly affected peak detection 
performance [58]. Evaluation of the alignment of LC-MS 
data using six freely available software packages, including 
XCMS [53], MZmine [56], msInspect [103] and OpenMS 
[55], concluded that no single software perfectly aligned the 
datasets [104]. The annotation of metabolite identities using 
fixed confidence thresholds has been recommended for data 
reporting, as has quantitative assessment of the annotation 
quality using the false discovery rate (FDR) [105]. Another 
approach is to provide a sophisticated graphical interface that 
enables specific steps of data processing to be rerun using 
different parameters [52]. Scripting tools may also be used to 
accelerate the optimization process and to minimize the need 
for user interactivity. Another possible means to improve 
performance entails the development of an iterative 
analytical framework with machine learning methods that 
allow the program to be trained to tune parameters using the 
difference between automated and manual data processing 
[59]. It is evident that subsequent statistical analysis will 
benefit if care is taken at the processing stage, and that 
automatic data processing for peak detection, alignment and 
annotation remain far from perfect. 
3. DATA ANALYSIS IN METABOLOMICS 
  Once a data matrix has been produced from raw data, 
subsequent steps usually involve different forms of statistical 
analysis and data mining to allow the identification of 
samples or variables (metabolites) that capture the bulk of 
variation between datasets and that may represent candidates 
for biologically meaningful variables. Typical analyses of 
metabolomic data consist of two phases; initially an 
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multivariate analysis and individual peaks are subsequently 
graded by univariable analysis. Here we briefly introduce 
several univariable and multivariate analyses, and 
classification and assessment methods that are widely used 
in analyzing MS-based metabolomics datasets (Fig. 2). 
Selected recent applications are then introduced. See also the 
recent reviews [37, 43]. 
3.1. Principal Component Analysis 
  Principal component analysis (PCA) is an unsupervised 
statistical analysis that is probably the most widely used 
statistical tool in metabolomics studies. PCA converts high-
dimensional data into fewer dimensions, by projecting the 
data into a reduced dimensional subspace, while maintaining 
as much variance from the original data as possible [106-
108]. The procedure is repeated until the datasets can be 
presented usually within two or three dimensions. This 
facilitates visual inspection of the distributed samples in 
principal component (PC) space, using score plots [33]. The 
Euclidian distance between individual samples in score plots 
reflects the degree of systematic variation in metabolite 
profiles among samples, and loading plots show the 
contribution of individual metabolites to each PC (Fig. 2A). 
Prior to the development of more effective data analyses, 
such as clustering, pattern recognition or classifications, the 
vast majority of metabolomic studies used PCA as a first 
exploratory step [37]. 
3.2. Cluster Analysis 
  Clustering analysis is a statistical method that involves 
dividing observed datasets into several subclasses or clusters 
based on a selected statistical distance function. There are 
two types of clustering algorithms: hierarchical and non-
hierarchical methods. Both algorithms partition the observed 
datasets into subgroups so that datasets with similar 
metabolomic profiles are placed in each subgroup [33]. 
Hierarchical clustering (HCL) (Fig. 2A) aligns datasets by 
generating dendrograms using the following procedure: 1) 
calculate the similarity of the two samples using a specific 
metric, such as Pearson correlation, Euclidean, mutual 
information and covariance values; 2) align the most similar 
samples as neighbors or pair them as a single cluster; and 3) 
reiterate step 1 and 2 until all samples are aligned [33]. Non-
hierarchical clustering (non-HCL) also divides data into 
clusters but without any hierarchical organization. The K-
means and fuzzy c-means methods are typical examples of 
non-HCL [33]. In the K-means method, k data points are 
initially randomly chosen to be close to the mean of each 
cluster, a new mean is then calculated for each cluster and 
the patterns are reassigned to the new means. This process is 
repeated until the cluster means are such that no pattern 
moves from one cluster to another [109]. The K-means 
method assigns each datapoint into only one cluster while 
the fuzzy c-means method allows data to be assigned to 
multiple clusters [110]. Fuzzy c-means also calculates the 
probability of a datapoint belonging to each cluster [111]. 
These analyses are widely used when the number of clusters 
for the samples is unknown, and can be used for one-time 
snapshot profiling as well as time-course data. 
3.3. Partial Least Squares Analysis 
  Partial least squares (PLS) (Fig. 2C), a regression-based 
method, builds a low-dimensional sub-space based on linear 
combinations of the original X variables. It makes use of 
additional Y information by adjusting the model to capture 
the (Y)-related variation into the original X variables [37]. 
PLS is particularly useful when fewer observations 
(samples) are available than measured variables 
(metabolites). In metabolomics, PLS-based classification and 
PLS-discriminant analysis (PLS-DA) have been widely used 
to sharpen the separation between groups or observations. 
This is achieved by rotating PCs to maximize the separation 
between known classes, and to elucidate the variables that 
carry the class separating information [33,112-113]. 
Similarly to loading plots in PCA, S-plots visualize both the 
covariance and the correlation between metabolites and the 
modeled class designation. The S-plot therefore helps to 
identify statistically significant and potentially biochemically 
significant metabolites, based both on contributions to the 
model and their reliability [114]. Despite its powerful ability 
to separate classes, care must be taken during fitting of PLS-
DA to the training detaining datasets, which exaggerate 
 
Fig. (2). Typical data analysis methods  used in the field of metabolomics. Score plots in PCA A), dendrograms of clustering B), score plots 
and S-plots of PLS-DA C), random forests model D), and ROC curve E). 
A)
PC1
P
C
2
PC1
P
C
2
Sample Metabolite
Score plots Loading plots
B)
dendrogram 
for samples
dendrogram 
for metabolites
Sample Metabolite
Score plots S-plots
C) D)
PC1
P
C
2
Covariance
C
o
r
r
e
l
a
t
i
o
n
S
e
n
s
i
t
i
v
i
t
y
1 - specificity
E)Bioinformatics for MS-Based Metabolomics  Current Bioinformatics, 2012, Vol. 7, No. 1    101 
generalization ability. Usually cross-validation or 
permutation tests are used to assess the ability of the trained 
PLS-DA model [115]. Orthogonal projections to latent 
structures (OPLS)-DA, an extension of PLS-DA featuring an 
integrated orthogonal signal correction filter to remove 
variability not relevant to class separation, has been used 
increasingly owing to its robustness against noise [21,116]. 
3.4. Random Forests 
  Random forests (RF) is a relatively new machine 
learning method typically used to discriminate two groups 
(Fig. 2D). The fundamental concept of RF is to allow data 
structures to be understood without dimensional reduction, 
and this method is therefore different from conventional 
methods such as PCA and PLS-DA. This classification 
algorithm was developed by Leo Breiman [117] and uses an 
ensemble of classification trees. Each of the classification 
trees is built using a bootstrap sample of the data, and at each 
split, the candidate set of variables is a random subset of the 
variables. Thus, RF uses both bagging (bootstrap 
aggregation), a successful approach for combining unstable 
learners, and random variable selection for tree building. 
Each tree is unpruned (grown fully) so as to obtain low-bias 
trees. At the same time, bagging and random variable 
selection result in low correlation of the individual trees 
[118]. The algorithm yields an ensemble that can achieve 
both low bias and low variance (by averaging over a large 
ensemble of low-bias, high-variance but low-correlation 
trees) [119]. 
3.5. Conventional Statistical Analysis 
  Because metabolomics generates data on multiple 
(dozens or hundreds) different metabolites, global overview 
methods that take into account the possible correlations 
between variables are the main tools used. However, when 
used appropriately, monovariate methods can also provide 
useful insight and remain widely used, especially for 
secondary biomarker analyses. 
  Although multivariate classification methods are often 
used to identify biomarkers, the discrimination of individual 
metabolites is usually assessed by conventional univariate 
statistical tests, such as Student’s t-test and the Mann-
Whitney test for two classes, or ANOVA and Kruskal-Wallis 
for multiple classes (3). Dependency or correlations 
between metabolites, inadequate sample size, and large FDR 
due to multiple hypothesis testing must be taken into account 
when applying these methods [120]. Corrections of the p-
value and/or calculation of false discovery rates must be 
carried out to limit the number of false positives that increase 
linearly with the number of variables [120]. Multivariate 
analysis has the advantage of considering the general 
patterns in the whole dataset, but it introduces additional 
challenges and sources of variability owing to the necessary 
data pre-treatment and scaling used to analyze all variables at 
once [61]. Thus, biomarkers should be rigorously evaluated 
by a combination of these statistical analyses and several 
validation methods, such as cross-validation and bootstrap 
analysis [121]. Recently, the FDR and receiver operating 
characteristics (ROC) methods have been frequently used to 
identify significantly different metabolites in the given 
classes. 
  The FDR method [122], is commonly used in gene 
expression analyses, and is now also used in metabolomic 
studies, [11], where a large number of variables are analyzed 
simultaneously, and thus multiple comparisons are 
conducted. In practice, FDR establishes a threshold for the 
significance level (q-value) that can be expected to represent 
false positives among all significant hypotheses to reject 
optimistic significance. To account for multiple 
comparisons, each FDR is estimated by the product of the 
significance level (Type I error rate) and the number of null 
hypotheses tested, divided by the number of null hypotheses 
rejected [123]. 
  A ROC [124] curve is a statistical representation that 
simultaneously expresses both sensitivity and specificity to 
separate binary class datasets, for example to discriminate 
healthy control and patient datasets. The curve is plotted by 
fractions of sensitivity as the Y-axis vs. fractions of false 
positive rate (1- specificity) as the X-axis (Fig. (2E)). The 
test is used to differentiate performance of one or a 
combination of biomarkers; an area under the curve (AUC) 
of 1.0 indicates perfect separation without any false 
negatives or false positives, while an AUC of 0.5 is 
equivalent to random separation only.  
  AUC evaluates only the rank of the metabolites 
associated with the given classes, and therefore it does not 
count fold-change or the concentration itself. Meanwhile, 
FDR evaluates the relative significance of the metabolites in 
a large group of metabolites. Thus, the use of a combination 
of different methods, along with multivariate analyses, can 
achieve more efficient screening than any single method. 
3.6. Data Mining Analysis 
  In addition to classification methods, other data mining 
methods have also been used in metabolomic data analyses 
to discriminate two classes, for example support vector 
machine (SVM) [125-126], artificial neural networks (ANN) 
[127] and decision tree [128]. ANN has been particularly 
widely used for various applications in MS-based studies, 
including in metabolite identification [97], classification 
[129], optimization of separation parameters [130] and QC 
of data processing [59] (see review [131]). In comparative 
study, a class of LC/MS peaks was predicted by four data 
mining techniques, k-NN, SVM, PLS-DA and Naïve Bayes, 
and revealed that the former two methods performed better 
than the latter two [132]. However, it is usually difficult to 
select the best method for the analysis of a given 
metabolomic dataset a priori, and the development of a 
pipeline with multiple analytical tools is therefore necessary. 
Visualization of metabolomic data in a pathway form also 
requires several data mining techniques. Small relevance and 
conditioned metabolic pathways have been predicted and 
then merged to generate pruned networks [133]. Small sub-
pathways were estimated with only relevant nodes, for 
example metabolite and enzymes, to reduce complexity and 
to enhance interpretability [134]. Both of these method 
attempts to find new relevant connections, rather than to 
assign the observed data to known maps. 
4. VISUALIZATION AND DATA SHARING 
  Here we discuss data visualization to facilitate the 
interpretation of large metabolomic profiles. Data 102    Current Bioinformatics, 2012, Vol. 7, No. 1  Sugimoto et al. 
standardization is also discussed to realize open and shared 
access to metabolomics technologies. 
4.1. Visualization of Metabolomics Data 
  Data visualization using a heatmap or a pathway form 
facilitates comprehension of the metabolomic 
change/response to the experimental setting. MetaboAnalyst 
visualizes experimental metabolomic data using heatmap 
visualization and offers common statistical analyses, such as 
PCA, PLS-DA, and HCL [135-136]. Pathway Project [137] 
visualizes data in the form of several graph types, such as bar 
graphs, time-courses and simple circles corresponding to 
metabolite concentration at the metabolite node on the 
KEGG pathway [138]. Similar web-based network 
visualization tools for BioCyc [139] are also available [140]. 
Both tools take advantage of Google Map API zoom and 
search functions, which can be helpful when looking for 
interesting details in large metabolomic datasets. The 
editable pathway tool is also useful when new molecular 
interactions that are not available in public database are to be 
explored [141]. 
4.2. Standardization of Metabolomics Data Reporting 
  In addition to the standardization of raw file format and 
data processing tools, the standardization of the reporting of 
metabolomic data information has also received attention. 
This would facilitate experimental replication, interrogation 
and comparison over multiple investigators and laboratories. 
The Metabolomics Society has formed five working groups, 
biological context metadata, chemical analysis, data 
processing, ontology and data exchange, to establish 
guidelines for reporting standards [142]. The Chemical 
Analysis Working Group, part of the Metabolomics 
Standards Initiative, proposed a set of minimum information 
that should be provided when reporting chemical analyses, 
and these included metadata from MS and NMR data, 
sample processing protocol, data processing, metabolite 
identification, and even unknown metabolites in the obtained 
dataset [143]. Attempts to define standards for data reporting 
have been made but unfortunately are still not widely used 
[35, 142-143]. To maximize the value of metabolomic 
datasets, it is important that data is made publicly available 
in formats, and with metadata, that are widely accepted as 
standard. In this sense, the field of metabolomics lags behind 
genomics and proteomics. Some of the reasons for this slow 
adoption of standards include the heterogeneity of analytical 
platforms and vendors, and the complexity of sample 
processing, which remains the focus of ongoing 
investigation. A Metabolomics Standard Initiative was 
recently initiated by the Metabolomics Society, and aims to 
develop standards for data exchange, ontology and 
guidelines for data reporting to solve some of the current 
issues (http://msi-workgroups.sourceforge.net/). 
5. SOFTWARE TOOLS 
  A number of free software packages are already available 
for the processing and analysis of metabolomic data, and 
Table 1 gives a sample directory of these. Both web services 
and desktop applications are available. The table is not 
necessarily exhaustive, but should help to identify commonly 
used solutions. Several statistical tools listed were designed 
for NMR data analyses but might be also useful for MS data 
analyses. Here, we focused only on tools used specifically in 
metabolomics studies, and did not review free or commercial 
generic software for multivariate analysis or other standard 
statistical analysis. We emphasize mainly tools for pre-
processing and data visualization. Moreover, details of these 
packages are not reviewed here, and the reader is referred to 
the original publication or project web site for more 
information. 
6. APPLICATIONS 
  Here, the use of statistical methods in several 
applications is discussed. Note that several of the statistical 
analysis applications introduced here used NMR data. The 
same multivariable techniques can technically be used for 
MS data analyses, but it should be noted that MS-data 
includes a larger number of variables (metabolites) and 
therefore more redundant variables. However, appropriate 
statistical analyses and MS data may provide more powerful 
insight into biological context. 
  PCA and PLS-DA have been the most popular and 
widely used analyses in metabolomic studies. Although PCA 
can visualize the similarities and differences in the observed 
data with unknown classes, it is generally used as a weaker 
classification tool for class known problems. It is therefore 
generally used as a first screening method for classification 
problems, prior to PLS-DA. For example, while PCA was 
able to give adequate separation resolution of various 
conditions, for example smokers and non-smokers in a 
salivary metabolite profile, PLS-DA was subsequently used 
to maximize resolution [144]. A similar approach was 
adopted for the discrimination of lung cancer sufferers using 
urine metabolomic profiles [116] and pancreatic cancer using 
serum metabolomic profiles [145]. HCL has also been used 
to assess data structure by aligning datasets based on their 
profile’s similarities [146-148], and this method is often used 
to classify samples with known classes, similarly to PCA. It 
has been applied to biomarker discovery, to classify control 
and patient groups, with key branches in its dendrogram 
indicating biomarker candidates [149]. Although this 
example was not a metabolomics application, a particularly 
successful example of HCL involved the clustering of gene 
expression in breast cancer, which suggested the existence of 
a new subtype of breast cancer in addition to the known 
classes [150]. The assessment of the analytical results of 
these methods can only be performed with known classes, 
and new findings should be analyzed further once 
consistency between results and known classes has been 
confirmed. 
  The over-fitting of a developed model to a given dataset 
should be carefully avoided, especially when using MS data, 
since it usually involves a large number of variables and 
small sample numbers. RF is expected to be a useful 
classification method when we use such datasets. Because 
the algorithm itself does not limit the application, RF has 
been used for biomarker discovery in urine metabolomic 
profiles from breast cancer patients [125] and in plant 
applications to explore genotype-dependent variables in 
metabolomic profiles in Arabidopsis and potato [151-152]. 
When RF and margin-based classifiers, such as SVM and 
PLS-DA, were compared, RF and SVM were found to have 
similar accuracy and both were slightly better than PLS-DA  Bioinformatics for MS-Based Metabolomics  Current Bioinformatics, 2012, Vol. 7, No. 1    103 
Table 1. Software List for Metabolomic Analysis 
Name  Main Application  Specific Features  Ref.  License  User Interface 
OpenMS  Raw data processing  C++ libraries for MS data processing, including 
feature detection and protein/peptide identification 
[57]  Lesser GNU 
Public License 
(LGPL)  
C++ library 
CDK-Taverna  Workflow  A workflow based data processing library for 
cheminformatics 
[156]  LGPL  Plug-in of Java 
Metabonomic 
Package 
Statistical analysis of NMR data  Multivariate analysis, such as PCA, PLS, k-nearest 
neighbor classification, neural networks. 
[127]  GPL  R language
*) 
metaXCMS  Importing XCMS output  Post processing of XCMS for comparison of multiple 
(3) classes and visualizing statistical analyses. 
[157]  Free  R language
*) and 
GTK 
XCMS  Processing LC-MS raw data  R module for data processing, including feature 
detection and peak alignment 
[53]  Free  R language
*) 
XCMS2  Importing tandem mass 
spectrometry (MS/MS) raw data 
Processing of tandem mass spectrometry data for 
metabolite identification and structural 
characterization 
[158] 
Free  Plug-in of R 
language
*) 
MeDDL  Data processing of LC-MS and 
GC/MS data 
A Matlab script for data processing and visualizing 
multiple datasets. 
[159]  Free  Matlab script 
MetaScape  Pathway visualization / statistical 
analysis 
A Cytoscape plug-in for visualizing and interpreting 
metabolomic data in the context of human metabolic 
networks 
[160] 
Free  Plug-in of 
Cytoscape 
MetaboliteDe
tector 
Importing NetCDF and FastFlight 
GC-MS data 
Comprehensive analysis, including chromatogram 
compression, feature detection, alignment and 
compound identification. 
[161] 
GNU public 
license (GPL) 
Local application 
(GUI) 
MetAlign 
Importing many common formats, 
including Masslynx, Xcalibur, 
netCDF, and the old-style 
HP/Agilent format of GC-MS / 
LC-MS data 
Interface-driven data processing program. Includes 
baseline correction, smoothing, feature detection and 
alignment 
[162] 
Free  Local application 
(GUI) 
MAVEN  Data processing of LC-MS and 
pathway visualization 
Tools for all aspects of data analysis, from feature 
extraction to pathway-based graphical data display 
[59]  Free  Local application 
(GUI) 
LIMSA  Data processing / mass 
spectrometric lipidome data 
Tool finds and integrates peaks in a mass spectrum and 
matches the peaks with a user-supplied list of expected 
lipids. 
[163] 
Free  Local application 
(GUI) 
centWave   Data processing of LC-MS data  Detection of close and partially overlapping features; 
also has the highest overall recall 
[68]  Free  Local application 
(GUI) 
mzMine2   Data processing of MS data 
Modular framework for processing, visualizing and 
analyzing mass spectrometry-based molecular profile 
data 
[52] 
Free  Local application 
(GUI) 
JDAMP  Data processing of CE-MS data  Data processing, alignment, differential display  [67]  Free for 
academic users 
Local application 
(GUI) 
CytoScape  Pathway visualization / statistical 
analysis 
Software for the visualization and analysis of 
biological networks 
[164]  Free  Local application 
(GUI) 
metaP-server  Statistical analysis, database 
searching, pathway visualization 
A web-based metabolomics data analysis tool  [165]  Free  Web 
MetDAT  Statistical analysis, database 
searching, pathway visualization 
A modular and workflow-based free online pipeline 
for mass spectrometry data processing, analysis and 
interpretation 
[166] 
Free  Web 
ChromaA  Alignment, chromatography-mass 
spectrometry 
Signal-based retention time alignment for 
chromatography-mass spectrometry data 
[167]  Free  Web 
MZedDB  Data processing  Interactive m/z annotation tool  [92]  Free  Web 
Pathway 
projector 
Pathway visualization  A Web-based zoomable pathway browser that uses 
KEGG atlas and Google Maps API 
[137]  Free  Web 
MetPA  Pathway visualization / statistical 
analysis 
A web-based metabolomics tool for pathway analysis 
and visualization 
[168]  Free  Web 
MetExplore  Pathway visualization  A web server to link metabolomic experiments and 
genome-scale metabolic networks 
[169]  Free  Web 104    Current Bioinformatics, 2012, Vol. 7, No. 1  Sugimoto et al. 
Table 1. cont… 
MSEA  Pathway visualization  A web-based tool to identify biologically meaningful 
patterns in quantitative metabolomic data 
[170]  Free  Web 
MetabolomeE
xpress 
Pipeline for data processing and 
statistical analysis of GC/MS data 
Data processing, statistical analysis (e.g. HCL), 
metabolite identification and heat map visualization 
[171]  Free access for 
non-commercial 
and academic 
users 
Web 
Chromaligner  Alignment of LC-MS data  Alignment of LC-MS chromatographs using the COW 
algorithm 
[172]  Free access  Web 
*) R language (http://www.r-project.org/). 
 
[125]. However, the accuracy of the model trained on the 
given dataset is not the only important factor. Validation, 
which involves confirming the generalizability of the 
model’s accuracy and the significance of selected variables 
in similar experiments, is important when such discriminate 
models are used. SVM and PLS-DA can also be used to rank 
the significance of variables constitutive to the models, while 
RF does not explicitly maximize the margin, which makes 
the trained model unbiased to the given datasets and is 
directly related to the generalizability [151]. Although 
several techniques to evaluate generalizability are known, 
including the permutation test, bootstrap test and cross-
validation [115], rigorous assessment has indicated that 
normal cross-validation is insufficient and overfitting may 
remain a problem [153]. Thus, careful and multilateral 
evaluation of the developed model is necessary. 
  After multivariate analysis, individual metabolites or sets 
of metabolites are usually accessed using univariate 
analyses. As ROC is a conventional statistical method that 
has been widely used for medical diagnosis problems, it has 
become popular in biomarker discovery applications. 
Multiple logistical regression models, composed of multiple 
metabolite markers to discriminate liver diseases [154] and 
oral cancers [155], were assessed using AUC values 
calculated from ROC. This revealed the discrimination 
possible when only a few metabolite sets are used, rather 
than all available data, which is used in PCA and PLS-DA. 
Approaches using all available metabolites are appropriate 
when studying overall variation, but are not useful for 
clinical usage, for example in the development of diagnosis 
techniques using a single or a few markers. Thus, integrative 
analyses using multivariate analysis, feature selection, and 
assessment of individual or a few markers are standard 
techniques that are useful for general purposes. 
  As should be apparent, multiple solutions exist for data 
processing, some of which are capable of performing most or 
all steps from raw data to statistical analysis, while others are 
specialized for certain steps or visualization. The selection of 
a data analysis solution is not straightforward and will 
depend on the analytical platform, the experimental design 
and data type, and on computational infrastructure, among 
other things. This review gives an overview of the options 
that can be chosen from, and highlights recent efforts to 
integrate these solutions to generate simple, yet powerful 
methods for the user. The field of data analysis for 
metabolomics is still rapidly evolving, and ongoing efforts 
are likely to produce further progress. There is a need for 
greater interchangeability and interoperability between tools, 
and unfortunately the profusion of new and interesting tools 
originating from numerous small groups often tends to limit 
this goal. Developers should consider these factors when 
promoting particular solutions. This will stimulate data 
sharing and exchange, and therefore improve adoption by a 
community of users who are often overwhelmed by a range 
of possibilities, and who may therefore tend to stick to tools 
that emphasize usability rather than quality or performance. 
  In this review article, we reviewed multiple tools for 
processing and analysis of MS data. Multiple metabolomics 
platforms together with the appropriate data processing and 
analysis tools can allow us to identify discriminating features 
in a set of samples, with multiple applications in research, 
diagnosis, etc. However, beyond class discrimination, 
understanding the biological mechanisms responsible for the 
variance in observed profiles remains an important issue. For 
this, the constant development and improvement of 
computational techniques for metabolite identification, 
accurate quantification, data integration, and pathway 
visualization is important and will continue to be the focus of 
bioinformatics efforts in the coming years.  
CONCLUSION 
  Remarkable improvements in analytical instruments, 
including MS, have enabled the profiling of metabolites with 
increasingly high throughput and high precision. 
Bioinformatics, which facilitates the interpretation of the 
output of these instruments, is essential to the successful 
analysis of large dataset metabolomic applications. Tool 
development must keep up with the improvements in 
analytical instruments and thus represents an important 
challenge, but has great potential to add value to 
metabolomic datasets. 
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